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ABSTRACT Carbapenem-resistant Enterobacteriaceae (CRE)haveemergedasmajorcausesofhealthcare-associatedinfections
worldwide.Thisdiversecollectionoforganismswithvariousresistancemechanismsisassociatedwithincreasedlengthsofhos-
pitalization,costsofcare,morbidity,andmortality.TheglobalspreadofCREhaslargelybeenattributedtodisseminationofa
dominant strain of Klebsiella pneumoniae producing a serine -lactamase, termed K. pneumoniae carbapenemase (KPC). Here
wereportanoutbreakofKPC-producingCREinfectionsinwhichthedegreeofhorizontaltransmissionbetweenstrainsand
speciesofapromiscuousplasmidisunprecedented.Sixteenisolates,comprising11uniquestrains,6species,and4generaof
bacteria,wereobtainedfrom14patientsovertheﬁrst8monthsoftheoutbreak.Ofthe11uniquestrains,9harboredthesame
highlypromiscuousplasmidcarryingtheKPCgene blaKPC.Theremainingstrainsharboreddistinct blaKPCplasmids,oneof
which was carried in a strain of Klebsiella oxytoca coisolated from the index patient and the other generated from transposition
oftheblaKPCelementTn4401.Allisolatescouldbegeneticallytracedtotheindexpatient.Molecularepidemiologicalinvestiga-
tionoftheoutbreakwasaidedbytheadaptationofnestedarbitraryPCR(ARB-PCR)forrapidplasmididentiﬁcation.Thisde-
tailedmoleculargeneticanalysis,combinedwithtraditionalepidemiologicalinvestigation,providesinsightsintothehighly
ﬂuiddynamicsofdrugresistancetransmissionduringtheoutbreak.
IMPORTANCE Theeaseofhorizontaltransmissionofcarbapenemaseresistanceplasmidsacrossstrains,species,andgeneraof
bacteriaobservedinthisstudyhasseveralimportantpublichealthandepidemiologicalimplications.First,ithasthepotentialto
promotedisseminationofcarbapenemresistancetonewpopulationsof Enterobacteriaceae,includingorganismsoflowviru-
lence,leadingtotheestablishmentofreservoirsofcarbapenemresistancegenesinpatientsand/ortheenvironmentandofhigh
virulence,raisingthespecterofuntreatablecommunity-associatedinfections.Second,recognitionofplasmid-mediatedout-
breaks,suchasthosedescribedhere,isproblematicbecauseanalysisofresistanceplasmidsfromclinicalisolatesislaboriousand
technicallychallenging.AdaptationofnestedarbitraryPCR(ARB-PCR)toinvestigatetheplasmidoutbreakfacilitatedourin-
vestigation,andthemethodmaybebroadlyapplicabletootheroutbreaksduetootherconservedmobilegeneticelements.
Whetherinfectioncontrolmeasuresthatfocusonpreventingtransmissionofdrug-resistantclonesareeffectiveincontrolling
disseminationoftheseelementsisunknown.
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E
nterobacteriaceae are responsible for a signiﬁcant number of
infections and death in the United States and worldwide each
year, and the prevalence of antibiotic resistance in this family of
bacteriacontinuestorise(1).Onereasonforthisincreasehasbeen
the dissemination of Klebsiella pneumoniae carbapenemase
(KPC),aclassAserinecarbapenemaseﬁrstisolatedfromK.pneu-
moniae in 1996 (2). blaKPC encodes KPC and is carried within the
conserved Tn3 family transposon Tn4401 on transferable plas-
mids (3). A dominant strain of KPC-producing K. pneumoniae,
multilocus sequence type (ST) 258, has disseminated throughout
the United States and other parts of the world (4, 5). Institutional
outbreaksofKPC-producingEnterobacteriaceaeduetothespread
of a single strain have also been reported for other species, in-
cluding Enterobacter spp. and Serratia marcescens (6, 7). While
these reports highlight the clonal nature of dissemination of
carbapenem-resistant Enterobacteriaceae (CRE), several cases of
horizontal transfer of blaKPC through transferable plasmids have
also been described (7–9).
Tn4401, a 10-kb Tn3 family transposon, serves as the ge-
netic support structure for blaKPC and is highly conserved.
Tn4401 has been characterized in more than seven different
plasmids, ranging 12 to 80 kb in size, each with a distinct in-
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been found in an isolate from China (11), all other reports and
deposited sequences in Tn4401 to GenBank to date have a
largely conserved structure and sequence.
InAugust2007weidentiﬁedtheﬁrstknowncaseofCREatour
institution(12),whichpromptedustoscreenallclinicalisolatesof
extended-spectrum -lactamase (ESBL)-producing enterobacte-
riaceae for carbapenemase production. In contrast to other re-
ported clusters, we observed a diversity of species and genera of
CRE from the outset of the outbreak. In this article, we describe
the molecular epidemiological characteristics of this heteroge-
neous outbreak of KPC-producing CRE.
RESULTS
Detection of KPC and in vitro antimicrobial susceptibility. Ap-
proximately280membersoftheEnterobacteriaceaewerescreened
for carbapenemase production by modiﬁed Hodge analysis dur-
ing the study period. Sixteen isolates (5.7%) from 14 patients had
positivephenotypiccarbapenemasetests.Fourgeneraandsixspe-
cieswererepresented:Enterobactercloacae(n6),K.pneumoniae
(n  4), Klebsiella oxytoca (n  3), Escherichia coli (n  1), En-
terobacter asburiae (n  1), and Citrobacter freundii (n  1) (Ta-
ble1).Two(14%)of14patientsharboredclinicalisolatesofmore
than one CRE species. PCR analysis determined that all isolates
carried blaKPC. According to 2009 Clinical and Laboratory Stan-
dardsInstitute(CLSI)breakpoints,mostisolatesweresusceptible
to imipenem (81%) by automated susceptibility testing, while 1
(6%) and 4 (25%) isolates were ertapenem susceptible and inter-
mediate, respectively (Table 1). Disk diffusion did not accurately
predict in vitro resistance; 15 (94%) isolates were imipenem or
meropenem susceptible, while one isolate (6%) was intermediate
(Table 1 and data not shown).
Clinicaloutcomes.Allpatientsdevelopedclinicallysigniﬁcant
infections with CRE (Table 1). All were adult inpatients with ma-
jor comorbidities who had been hospitalized for a median of
31 days prior to the ﬁrst isolation of CRE. A summary of the
demographic and clinical characteristics are presented in Table 2.
Caseswereidentiﬁedthroughoutthehospital:eightintensivecare
units, ﬁve medical or surgical wards, and one oncology care unit.
Investigation of the outbreak revealed possible epidemiological
links between most but not all of the cases. While 93% had re-
ceived broad-spectrum antibiotics prior to infection with CRE,
only 36% had received a carbapenem. All-cause 28-day mortality
TABLE 1 Isolate description and carbapenem susceptibilitiesa
Patient Isolate Species
Date of
ﬁrst
isolationb Source(s)
MIC (g/ml)
determined by
Vitek 2
Imipenem
disk
diffusion
(mm)
Pulsed-
ﬁeld
group
Sequence
group Plasmid Outcome Imipenem Ertapenem
1 Kox1015 Klebsiella oxytoca 8/31/2007 Blood,
drain,
BAL ﬂuid
4 >8 16 pfg-kox1 sg2 pUVA02 Died
Kpn1016 Klebsiella
pneumoniae
8/31/2007 Drain,
sputum
>16 >8 16 pfg-kpn1 sg1 pUVA01 Died
2 Kpn1017 Klebsiella
pneumoniae
10/05/2007 Blood,
sputum,
urine
84 17 pfg-kpn1 sg1 pUVA01 Died
3 Ecl1026 Enterobacter cloacae 11/30/2007 Sputum,
urine
4 >8 20 pfg-ecl3 sg1 pUVA01 Recovered
4 Ecl1027 Enterobacter cloacae 12/09/2007 Urine 2 4 19 pfg-ecl2 sg1 pUVA01 Recovered
5 Kox1028 Klebsiella oxytoca 1/15/2008 Blood,
sputum
4 >8 20 pfg-kox1 sg2 pUVA02 Died
6 Ecl1032 Enterobacter cloacae 1/24/2008 Blood,
ascites ﬂuid
>16 >8 14 pfg-ecl4 sg1 pUVA01 Recovered
7 Eco1036 Escherichia coli 2/7/2008 BAL ﬂuid 1 1 19 n/ac sg3 pUVA03 Recovered
8 Ecl1034 Enterobacter cloacae 2/15/2008 Blood,
sputum
2 >8 18 pfg-ecl1 sg1 pUVA01 Died
9 Ecl1035 Enterobacter cloacae 2/20/2008 Blood,
urine
4 >8 18 pfg-ecl1 sg1 pUVA01 Died
10 Ecl1033 Enterobacter cloacae 2/20/2008 BAL ﬂuid,
sputum
2 >8 17 pfg-ecl1 sg1 pUVA01 Recovered
11 Eas1043 Enterobacter
asburiae
3/18/2008 BAL ﬂuid,
sputum,
wound
4 4 19 n/ac sg1 pUVA01 Died
Kpn1041 Klebsiella
pneumoniae
4/8/2008 Blood,
sputum
2 >8 21 pfg-kpn2 sg1 pUVA01 Died
12 Cfr1047 Citrobacter freundii 3/21/2008 Urine 1 4 19 n/ac sg1 pUVA01 Died
13 Kox1039 Klebsiella oxytoca 3/31/2008 Sputum,
urine
4 >8 20 pfg-kox1 sg2 pUVA02 Recovered
14 Kpn1042 Klebsiella
pneumoniae
4/6/2008 Urine 1 >8 18 pfg-kpn3 sg1 pUVA01 Recovered
a Boldface values indicate intermediate or resistant susceptibilities by MIC testing. Patients 1 and 2 have been described previously (12).
b Month/day/year.
c n/a, not applicable.
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(Table 2).
Genetic evaluation of Tn4401. Bidirectional sequencing of
blaKPC from isolates Kox1015, Kpn1016, and Eco1036 and align-
ment analyses revealed 100% identity to the blaKPC-2 allele. Using
the primer sets listed in Table S1 in the supplemental material,
PCRscreeningshowedthatallisolatescarriedblaKPCandallother
putative coding elements of Tn4401 and had a genetic organiza-
tion congruent with other previous reports (see Fig. S1) (3).
Several isoforms of Tn4401 have been characterized, differing
by the presence of deletions in the intergenic region between the
istBandblaKPCgenes(3,4).Inthisstudy,PCRampliﬁcationofthe
istB-blaKPCintergenicregioninall16isolatesproducedamplicons
consistent with a 757-bp product (see Fig. S1 in the supplemental
material; also data not shown), demonstrating that none con-
tained a large deletion in this nonconserved region of Tn4401.
Genetic relatedness. Pulsed-ﬁeld gel electrophoresis (PFGE)
wasperformedonspeciesthatwererepresentedbymorethanone
isolate. A striking degree of genetic diversity was observed among
theE.cloacaeandK.pneumoniaeisolates:fourpulsed-ﬁeldgroups
(pfg’s) were identiﬁed among the six E. cloacae isolates, and three
pfg’s were identiﬁed among the four K. pneumoniae isolates. In
contrast,allthreeK.oxytocaisolateswereofasinglepfg(Fig.1;see
also Table 1).
Plasmid evaluation. To identify the causative KPC-encoding
plasmid during the course of the investigation, we adapted the
nested arbitrary PCR (ARB-PCR) method to identify the DNA
sequence ﬂanking the Tn4401 insertion site. A schema of this
method is presented in Fig S2 in the supplemental material. This
technique has previously been used in genetic studies of bacterial
virulencetorapidlyidentifytheinsertionsiteoftransposonchro-
mosomal disruptions (13, 14).
Tn4401-ﬂankingDNAsequencewasobtainedfrom15isolates;
one isolate, Ecl1032, could not be analyzed by the ARB-PCR
method despite repeated attempts. Sequence lengths were on av-
erage 561 bp (range, 249 to 703 bp). Flanking sequences of 11
isolates were determined to be of the same sequence group (sg),
sg1, suggesting that the isolates carried the same KPC-encoding
plasmid. The Tn4401 insertion site for sg1 was in the transposase
genetnpA(99.6%identityover509bp;Evalue,5e202;GenBank
accessionno.FJ410927).ThethreerelatedK.oxytocaisolateswere
of the same sequence group, sg2, with a Tn4401 insertion site in a
novel open reading frame. The solitary E. coli isolate has a unique
sequence group, sg3, characterized by a Tn4401 insertion site in a
gene encoding a MobA-like relaxase (97.9% identity over 390 bp;
GenBankaccessionno.AY589571).Inallcases,theTn4401inser-
tion sites identiﬁed by these sequence groups were distinct from
corresponding transposon insertion sites found in previously de-
scribed blaKPC-containing plasmids.
To verify the ﬁndings obtained by ARB-PCR, Southern blot
analysis of plasmid DNA from isolates representing each pfg was
performed (Fig. 2). Gel electrophoresis demonstrated that
pUVA01, pUVA02, and pUVA03 were of 54, 80, and 22-kb, re-
spectively (12; data not shown), and Southern hybridization con-
ﬁrmed that all isolates harbored blaKPC plasmids (Fig. 2A and B).
Additional Southern hybridization conﬁrmed that all sg1 isolates
(but not the sg2 or sg3 isolates) and Ecl1032 hybridized to the
sg1-speciﬁc probe, while only the K. oxytoca and C. freundii iso-
lates hybridized to the sg2-speciﬁc probe (Fig. 2C and D).
Functional carbapenemase encoded by plasmid-borne blaKPC
was conﬁrmed by the generation of the pUVA01 and pUVA02
transformants AMGH01-T and AMGH07-T, respectively. The
transformants had positive modiﬁed Hodge tests and were con-
ﬁrmed by PCR to carry blaKPC, all other elements of Tn4401, and
the original sg designation. Interestingly, AMGH01-T had signif-
icantly reduced carbapenem MICs compared to those of
Kpn1016, whereas carbapenem MICs for AMGH07-T were com-
parable those for Kox1015 (Table 2).
Plasmid DNA of the transformants and representative CRE
isolates was subjected to restriction digestion with KpnI and
Southern blot analysis using blaKPC, sg1, and sg2 hybridization
probes (Fig. 3). For plasmid digests of the sg1 isolates Kpn1016,
Ecl1027, Cfr1047, and AMGH01-T, the blaKPC and sg1 probes
hybridized to a 20-kb fragment. Similarly, for digests of the sg2
isolate K. oxytoca Kox1028 and AMGH07-T, the blaKPC and sg2
probes hybridized to a 10-kb fragment. Plasmid digest of the sin-
gle sg3 isolate, E. coli Eco1036, hybridized to the blaKPC probe but
neither the sg1 nor the sg2 probe. These results conﬁrmed that
sequencegroupsdeterminedbyARB-PCRcorrectlyidentiﬁedthe
resistance plasmid carried by the CRE strain.
Southern blot hybridization of Cfr1047 with the blaKPC
probe also revealed a second, lower-molecular-weight frag-
ment, suggesting the presence of two plasmids with the KPC
gene (Fig 3). Furthermore, a second band in both Ecl1027 and
Cfr1047 hybridized to the sg1 but not the blaKPC probe. To-
gether, these results demonstrate that the clonal K. oxytoca
isolates harbor a single KPC resistance plasmid, pUVA02, the
single E. coli isolate carries a unique blaKPC-containing plas-
mid, pUVA03, and the remaining 12 isolates (representing 9
[82%] of the 11 unique outbreak strains) carry a highly pro-
TABLE 2 Demographics and clinical characteristics
Characteristic
Value for
case patientsa
Mean age, yr (range) 60 (23–81)
Male 8 (57)
Comorbid conditions
Transplant recipient 5 (36)
Diabetes mellitus 4 (29)
Renal insufﬁciency 4 (29)
Chronic heart disease 3 (21)
Malignancy 2 (14)
Health care-associated risk factors
ICU stay  48 h 9 (64)
Any ICU stay 11 (79)
Median length of stay prior to infection,
days (range)
31 (3–144)
Prior anti-Gram-negative antibiotic 13 (93)
Beta-lactam/beta-lactamase inhibitor 8 (57)
Fluoroquinolone 7 (50)
Broad-spectrum cephalosporin 5 (36)
Carbapenem 5 (36)
Monobactam 2 (14)
Clinical infection
Bacteremia 7 (50)
Urinary tract infection 7 (50)
Pneumonia 7 (50)
Intra-abdominal infection 3 (21)
Mortality 7 (50)
Bacteremia 6 (86)
a n  14. Data are no. (%) of patients unless otherwise indicated.
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also demonstrated that Cfr1047 harbors a second uncharacter-
ized blaKPC plasmid and that Ecl1027 and Cfr1047 harbor plas-
mids that share homology with the Tn4401 plasmids identiﬁed
by ARB-PCR. These results illustrate the diverse nature of as-
sortments of resistance plasmids found in multidrug-resistant
members of the Enterobacteriaceae (15).
Combining the molecular epidemiology of strain and resis-
tance plasmid typing with classic epidemiological evaluation of
CRE infection provides valuable insight into the dynamics of
blaKPC dissemination during this outbreak (Fig. 4). Transmission
of carbapenem resistance occurred primarily through horizontal
interstrain or interspecies transfer of the Tn4401-bearing plasmid
pUVA01 and, to a lesser extent, transmission of isogenic strains
between patients. The spread of blaKPC correlated well with
epidemiological risk factors, including the patient’s geographical
location, health care team, and time period of possible exposure
(Table 3; see also Fig. S3 in the supplemental material). We hy-
pothesize that pUVA03 acquired Tn4401 via mobilization from
pUVA01orpUVA02,giventhecongruityofthetransposonstruc-
ture and the patient’s epidemiological risk factors. Consequently,
all CRE infections appear to be linked to the index patient.
FIG1 Pulsed-ﬁeldgelelectrophoresisofoutbreakisolatesofthesamespecies.(A)AllthreeK.oxytocaisolatesareasinglestrain.(B)FourK.pneumoniaeisolates
are three distinct strains. (C) Six E. cloacae isolates are four distinct strains.
FIG2 PlasmidelectrophoresisandSouthernblotanalysisofalluniqueoutbreakclones.(A)PlasmidDNAelectrophoresisresolvedona0.6%agarosegelstained
with ethidium bromide. Southern blot of gel A with a blaKPC-speciﬁc probe (B), sg1-speciﬁc probe (C), or sg2-speciﬁc probe (D). Lanes: 1, Kpn1014 (negative
control);2to4,K.pneumoniae;5to7,E.cloacae;8,E.asburiae;9,C.freundii;10,K.oxytoca;11,E.coli.SupercoiledandrelaxedblaKPC-hybridizingplasmidDNA
was obtained from E. coli strain Eco1036.
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While sometimes difﬁcult to recognize, plasmids have previously
been linked to outbreaks of drug-resistant Gram-negative bacte-
ria. In 1985, O’Brien and colleagues reported an outbreak of
plasmid-mediatedgentamicinresistance,whichmovedtosixspe-
ciesoftheEnterobacteriaceaeover8yearsingeographicallydiverse
areas of the United States and Venezuela (16). Outbreaks of en-
terobacteriaceae resistant to sulfonamides, -lactams hydrolyzed
by ESBL, aminoglycosides, and ﬂuoroquinolones have also been
reported (17–21). Most recently, a multispecies outbreak of
plasmid-mediated VIM-1 metallo-carbapenemase has been re-
ported in Spain (22), and A/C-type plasmid carriage of the New
Delhi metallo--lactamase gene blaNDM-1 has emerged in Entero-
bacteriaceae in India and the United Kingdom (22). While move-
ment of blaKPC-containing plasmids between Enterobacteriaceae
has been described (7, 8, 23, 24), the degree of horizontal trans-
mission between strains and species observed in this outbreak is
unprecedented.
Why did the outbreak of CRE occur in such a wide assortment
of strains in our institution? One possibility is that the plasmid-
mediated nature of the outbreak may indicate that pUVA01 is
moremobilethanotherblaKPCplasmids.Thisissupportedbythe
observation that pUVA01 moved between a wide array of strains
over a short period of time, often in the absence of carbapenem
pressure. In contrast, horizontal transmission of pUVA02 or
pUVA03wasnotobservedduringthestudyperiod.Clearly,facile
transferofblaKPCplasmidsaddsanadditionallayerofcomplexity
to the epidemiology of this rapidly spreading resistance mecha-
nism. A second possibility is that by screening all possible ESBL-
producing Enterobacteriaceae, we may have captured non- or
weakly lactose-fermenting KPC-producing organisms that may
have been overlooked in a targeted surveillance and evaluation
program, as well as organisms with low carbapenem MICs that
would otherwise have been considered carbapenem susceptible.
Regardlessoftheetiology,wepredictthatthediversenatureofthis
outbreak will render detection and control of CRE spread even
more problematic if it becomes increasingly widespread.
FIG3 SouthernblotanalysisofKpnI-digestedplasmidDNAofrepresentativeoutbreakclonesandresistanceplasmidtransformants.(A)Restrictiondigestsof
plasmid DNA electrophoresis resolved on a 0.6% agarose gel stained with ethidium bromide. (B to D) Southern blot of gel A with a blaKPC-speciﬁc probe (B),
sg1-speciﬁcprobe(C),orsg2-speciﬁcprobe(D).Lanes:L,ladder;1,Kpn1014(negativecontrol);2,Kpn1016;3,Ecl1027;4,Cfr1047;5,Kox1028;6,Eco1036;7,
blank; 8, AMGH01-T; 9, AMGH07-T.
FIG 4 Hypothesized possible route(s) of spread of blaKPC between patients
based on plasmid proﬁles and epidemiological risk for CRE acquisition. Each
number denotes a patient. Shape and color denote the plasmid type: blue
circle,pUVA01;redtriangle,pUVA02;blackdiamond,pUVA03.Solidarrows
denote a possible route of spread based on shared plasmids and epidemiolog-
ical risk factors. Dashed arrows denote a possible route of spread without a
sharedplasmidtype.Notethatarrowsdonotnecessarilysignifydirectpatient-
to-patienttransmission;thespreadofCREmayhaveoccurredtoasourcethat
shared the same epidemiological space as the infected patient.
TABLE 3 Transformed strains
Strain Plasmid MHT resulta
MIC (g/ml)
determined by Vitek 2
Imipenem Ertapenem
AMGH01-T pUVA01  1 0.5
AMGH07-T pUVA02  4 8
a MHT, modiﬁed Hodge test.
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PCR to rapidly identify causative KPC resistance plasmids during
theinvestigation.Thistechnologyallowedustoquicklyrecognize
thehighdegreeofgeneticrelatednessamongtheoutbreakisolates
at the level of plasmid carriage—relationships missed by tradi-
tional species- and strain-based analysis. Investigations of so-
called “plasmid outbreaks” are difﬁcult for all but sophisticated
molecularepidemiologylabs.Analysisoflargeresistanceplasmids
from clinical isolates of the Enterobacteriaceae, such as the ones
observed in this study, can be laborious and technically challeng-
ing.ARB-PCRallowsrapiddeterminationofDNAsequencesthat
ﬂank a conserved element, which can be used as the molecular
signature for a transmissible plasmid. Given its simplicity, ARB-
PCRshouldbetranslatabletonotonlytransposonsbutalsoresis-
tance genes and other conserved components of mobile DNA el-
ements. ARB-PCR does have several limitations. A product may
notabletobegeneratedfromallsamples,aswasseeninthisstudy.
However, we were able to obtain products in all but one of our
isolateswithoutoptimizationoftheprotocolconditionsorprimer
sets.Anotherlimitationisthatonlyoneproductwillbegenerated
from an isolate, even if it contains more than one plasmid with
blaKPC, as was found with isolate Cfr1047. Finally, generation of
ﬂankingsequencedoesnotensurethattheproductnecessarilyhas
aplasmidorigin;transferofdrugresistancetoarecipientbacterial
strainanddemonstrationofaplasmid-encodeddrug-resistantde-
terminant are required to prove the presence of a resistance plas-
mid in the donor strain.
The ease of horizontal transmission of carbapenem resistance
observed in this study has serious public health and epidemiolog-
icalimplications.DisseminationofblaKPCthroughmobilegenetic
elements could allow carbapenem resistance to move to the com-
munity, as has been observed with the worldwide emergence of
community-onsetCTX-M-15-lactamase-producingE.coli(25–
28). Additionally, transmission of blaKPC to enterobacteriaceae of
reduced or no virulence could lead to the establishment of a res-
ervoir of carbapenem resistance genes in patients and/or the en-
vironment. Understanding the dynamics of blaKPC horizontal
gene transfer will be crucial to limiting the spread of CRE, since
epidemiological and containment efforts must focus not only on
thespreadofmultidrug-resistantstrainsbutalsoontheassociated
resistance plasmids and transposons.
MATERIALS AND METHODS
Patients and bacterial isolates. This study was conducted at the Univer-
sity of Virginia (UVA) Medical Center, a 619-bed tertiary care hospital in
central Virginia, from 1 September 2007 to 30 April 2008. Following the
detection of the ﬁrst case of CRE at UVA (12), all clinical Enterobacteri-
aceae isolates identiﬁed as possible extended-spectrum -lactamase
(ESBL) producers by automated testing (Vitek 2; bioMérieux, Durham,
NC)wereprospectivelyscreenedforcarbapenemaseproductionusingthe
direct carbapenemase and modiﬁed Hodge tests (29, 30). Species identi-
ﬁcation and antibiotic susceptibility testing were performed using the
Vitek2systemwiththeAST-GN18card(bioMérieux).Imipenemsuscep-
tibility was determined by the Kirby-Bauer disk-diffusion and broth mi-
crodilution methods in accordance with CLSI guidelines (31). Patient
characteristics, antibiotic exposure, and outcomes were obtained from
clinicalrecords.Forthisstudy,epidemiologicalriskfactorsforacquisition
ofCREweredeﬁnedashospitalizationonthesameﬂoorasapatientwith
CRE infection or receipt of care from a health care team concurrently
caring for a patient with CRE infection. Infection was deﬁned as isolation
of CRE from a clinical specimen which necessitated treatment. Mortality
was deﬁned as death from any cause within 28 days of the latest positive
clinical culture with CRE. The study protocol was approved by the UVA
Institutional Review Board for Health Sciences Research (no. 13558).
Bacteria,media,andreagents.Strainsandoligonucleotidesarelisted
inTable1(seealsoTableS1inthesupplementalmaterial).Enzymeswere
obtained from New England Biolabs (Ipswich, MA). Strains were rou-
tinely grown at 37°C on Luria-Bertani (LB) broth or agar supplemented
with freshly prepared 0.1-g/ml meropenem (AstraZeneca, Wilmington,
DE). All strains were stored at 75°C in LB broth containing 15% glyc-
erol.DNAsequencingwasperformedbytheUVABiomolecularResearch
Facility (Charlottesville, VA).
Genetic conﬁrmation of blaKPC and Tn4401. PCR ampliﬁcation of
blaKPCwasperformedonallisolatesaspreviouslyreported(2),andblaKPC
alleleidentiﬁcationwasperformedbybidirectionalDNAsequencingfora
representative strain of each strain type. Conﬁrmation of additional ele-
mentsoftheTn4401transposonwasperformedbyPCRusingtheprimer
sets listed in Table S1 in the supplemental material. For each sample,
whole-cell lysate was prepared as follows: an individual bacterial colony
was suspended in 100 l sterile water, boiled at 95°C for 10 min, and
centrifugedat16,100gfor1mintosedimentcelldebris,and2lofthe
supernatant was used as template DNA for PCR. PCR experiments were
carriedoutusingthefollowingconditions:3minofinitialdenaturationat
95°C, and 30 cycles of 30 s of denaturation at 95°C, 30 s of annealing at
57°C,a45-sextensionat72°C,andaﬁnalextensionof5minat72°Cwith
positive and negative K. pneumoniae controls for each run.
PFGE. Genotypic analysis was performed by PFGE of XbaI-digested
total DNA with the Chef mapper system (Bio-Rad, Hercules, CA) using
conditions outlined in the PulseNet protocol for the Enterobacteriaceae
(32).DendrogramconstructionwasperformedusingtheDicecoefﬁcient
and unweighted-pair group method using average linkages (UPGMA)
clustering(BioNumerics5.10;AppliedMaths,Austin,TX).Forthisstudy,
isolates of the same species were considered to share a common pulsed-
ﬁeldgroup(pfg)iftheyhadaDicesimilaritycoefﬁcientgreaterthan0.90.
Rapid determination of Tn4401 insertion site: ARB-PCR. DNA se-
quences ﬂanking the Tn4401 plasmid insertion site were determined us-
ing the nested arbitrary PCR (ARB-PCR) method (13, 14). The method
entailstwosequentialroundsofPCRampliﬁcationusingthetransposon-
speciﬁc primer AM14 and the arbitrary primer Arb1.1 in the ﬁrst round
and the nested primers AM11 and Arb2.1 in the second round, followed
byDNAsequencingusingprimerAM13(seeTableS1inthesupplemental
material).K.pneumoniaeKpn1014,whichlacksaKPCresistanceplasmid,
andsteriledouble-distilledwater(ddH2O)servedasnegativecontrolsfor
both rounds of PCR ampliﬁcation and DNA sequencing. Each isolate
underwent ARB-PCR and DNA sequencing twice, and the resultant
Tn4401insertionsitesequenceswerealignedusingtheClustalWsoftware
program to assess the degree of identity. Isolates carrying plasmids with
DNA sequences ﬂanking the Tn4401 integrant that had a BLAST E value
of 1e50 and 95% identity by pairwise analysis and the same trans-
poson insertion site, as determined by visual inspection, were considered
to be of the same sequence group (sg). Unidirectional sequencing of the
region ﬂanking Tn4401 (~1.5 to 2.4 kb) was performed on distinctive
plasmids.
Plasmidcharacterization.Todifferentiatebetweenplasmidsisolated
inthestudy,primersetstargetingthesequencegroupswereusedforPCR
analysis (see Table S1 in the supplemental material).
Southernblothybridizationusingsg-speciﬁcampliconsasprobeswas
performed to conﬁrm sg designations. Plasmid DNA was isolated using
the Qiagen Plasmid Midi kit (Qiagen) using 60°C prewarmed eluting
buffer. Uncut plasmid DNA was subjected to electrophoresis in a 0.6%
UltraPure DNA-grade agarose (Bio-Rad) gel at 70 V for 20 h at 4°C in
0.5 Tris-borate-EDTA buffer. Migration distances of the DNA were
compared to reference plasmids of E. coli strain V517. For restriction site
analysis, plasmid DNA was digested with KpnI at 37°C overnight and
subjected to electrophoresis in a 0.7% agarose gel at 80 V for4hi nTris-
acetate-EDTAbuffer.ForSouthernblothybridization,plasmidDNAwas
immobilizedtoanAmershamHybondNnylonmembrane(GEHealth-
Mathers et al.
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linker(AgilentTechnologies,SantaClara,CA).Membranesweresequen-
tiallyhybridizedwithPCRampliconprobesgeneratedforblaKPC,sg1,and
sg2 (see Table S1 in the supplemental material) labeled using the ECL
Direct nucleic acid labeling and detection system (GE Healthcare) in ac-
cordance with the manufacturer’s instructions.
Transfer of plasmid and carbapenemase phenotype. In order to de-
termine if carbapenem resistance was attributable to carriage of the
Tn4401element,plasmidDNAextractsfromKox1015(forpUVA02)and
Kpn1016 (for pUVA01) were transferred into E. coli GeneHog (Invitro-
gen)byelectroporation.TransformantswereselectedonLBmediumsup-
plementedwithmeropenem.Phenotypiccarbapenemaseresistanceofthe
transformants was determined by the modiﬁed Hodge test (29). Clinical
isolates and transformants were veriﬁed to carry resistance plasmids via
PCR analyses and Southern blot hybridization.
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